Copyright
©The Author(s) 2024.
World J Nephrol. Dec 25, 2024; 13(4): 98880
Published online Dec 25, 2024. doi: 10.5527/wjn.v13.i4.98880
Published online Dec 25, 2024. doi: 10.5527/wjn.v13.i4.98880
Parameter | Stage 1 (n = 76) | Stage 2 (n = 30) | Stage 3 (n = 11) | Stage 4 (n = 3) | P value |
Albumin creatinine ratio | 240.17 ± 633.921,2,3 | 1078.1 ± 2231.04 | 1344.09 ± 1420.74 | 1860 ± 1893.2 | 0.002 |
Neutrophil gelatinase-associated lipocalin (µg/L) | 6.36 ± 2.791,2,3 | 8.27 ± 3.15 | 8.27 ± 1.79 | 9.67 ± 2.3 | 0.003 |
Kidney injury molecule-1 (ng/mL) | 1.67 ± 1.023 | 2.1 ± 0.84 | 2.45 ± 1.12 | 2.67 ± 0.57 | 0.017 |
Periostin (ng/mL) | 51.04 ± 20.012,3 | 52.63 ± 19.11 | 66.82 ± 9.98 | 69.67 ± 4.5 | 0.034 |
- Citation: Varatharajan S, Jain V, Pyati AK, Neeradi C, Reddy KS, Pallavali JR, Pandiyaraj IP, Gaur A. Neutrophil gelatinase-associated lipocalin, kidney injury molecule-1, and periostin: Novel urinary biomarkers in diabetic nephropathy. World J Nephrol 2024; 13(4): 98880
- URL: https://www.wjgnet.com/2220-6124/full/v13/i4/98880.htm
- DOI: https://dx.doi.org/10.5527/wjn.v13.i4.98880